NCT03544983Enrolling by invitation
Genetic Education in BRCA Families
A Randomized Trial of Proactive Outreach and Streamlined Genetic Education in BRCA Families
Source: ClinicalTrials.gov · Last updated 29 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary goal of this research is to test a web-based genetic education intervention that is designed to educate men and women from hereditary cancer families about the personal relevance of genetic testing in order to help them male decisions about whether to pursue genetic testing. We will test this intervention against standard care for men and women from hereditary cancer families. The web-based educational intervention includes all of the information typically covered during genetic counseling. As a result, after completing the education intervention, participants can proceed directly to a brief telephone call with a genetic counselor followed by testing if they choose. A baseline survey will be administered prior to randomization and then follow-up surveys will be administered at 1-month and 6-months post-randomization. Primary outcomes will be completion of genetic counseling, uptake of genetic testing, genetic test results and quality of life.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- First submitted
- 22 May 2018
- Start date
- 1 May 2020
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Georgetown University
- Diseases
- Prostate cancer, Ovarian cancer
- NCT number
- NCT03544983
What you commit to
- Study type: Interventional
- Planned participants: 240
- From 1 May 2020 to the primary completion date, 31 Dec 2026
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior genetic testing for hereditary breast/ovarian cancer
Other illness
- Personal diagnosis of metastatic cancer
Other
- Have one or more children who have tested positive for a BRCA1 or BRCA2 mutation
- Cannot participate in or understand English
- Cannot provide meaningful informed consent
Who the study is looking for
- A first- (sibling, adult offspring) or second-degree (aunt/uncle, niece/nephew if at-risk parent is deceased) biological relative of an individual with a recently identified BRCA1 or BRCA2 mutation
Age in the registry: 21 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dana-Farber Cancer Institute Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| Geisinger Medical Center Coordinator of this site? Confirm its status | Danville | United States | Unknown status |
| Georgetown University Medical Center - Lombardi Comprehensive Cancer Center Coordinator of this site? Confirm its status | Washington D.C. | United States | Unknown status |
| George Washington University Coordinator of this site? Confirm its status | Washington D.C. | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.